Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
JACC. Heart Failure|September 24, 2025
Effects of Glucagon-Like Peptide 1 Receptor Agonist Initiation in Patients With Heart Failure With Reduced Ejection Fraction and Implantable Cardiac DevicesPedro Marques, Christoforos K Travlos, Paula Matias, et al.
European Journal of Heart Failure|August 10, 2023
Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitorsPedro Marques, Paula Matias, Milton Packer, et al.
Diabetes, Obesity & Metabolism|June 4, 2024
Utilizing synchronous care to improve cardiovascular and renal health among patients with type 2 diabetes: Proof-of-concept results from the DECIDE-CV clinical programmePedro Marques, Thomas A Mavrakanas, Julian Guida, et al.
Current Heart Failure Reports|August 24, 2021
Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment StrategiesPishoy Gouda, Sijia Zheng, Tricia Peters, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 23, 2026
Cost-effectiveness of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists for patients with high cardiovascular risk and type 2 diabetes in CanadaEthan S McNally, Pedro Marques, Elite Possik, et al.
Clinical Transplantation|July 25, 2017
Neutropenia in kidney and liver transplant recipients: Risk factors and outcomesThomas A Mavrakanas, Marie-Andrée Fournier, Sarah Clairoux, et al.
Diabetes Care|January 22, 2024
Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE TrialsSheldon W Tobe, Thomas A Mavrakanas, Harpreet S Bajaj, et al.
Kidney Medicine|April 17, 2024
Medication Deprescribing in Patients Receiving Hemodialysis: A Prospective Controlled Quality Improvement StudyÉmilie Bortolussi-Courval, Tiina Podymow, Marisa Battistella, et al.
Diabetes, Obesity & Metabolism|September 20, 2024
Cardiovascular phenotypes in type 2 diabetes: Latent class analysis of the CANVAS Program and CREDENCE trialAmir Razaghizad, Jiayi Ni, Pedro Marques, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 24, 2019
Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-AnalysisThomas A Mavrakanas, Yiannis S Chatzizisis, Karim Gariani, et al.
Pageof 7